Kolokvijalno reeno dabe ste kreili
your prescribing doctor would likely not debate between Wegovy and Mounjaro because those brands are prescribed for two different purposes (weight loss and diabetes, respectively), even though the active medications (semaglutide and tirzepatide) are each prescribed for both weight loss and diabetes
The incretin effect of GLP-1 receptor agonists (GLP1a) in the medical management of obesity is well documented [4, 5] by stimulating insulin release, suppressing glucagon secretion, reducing gastric emptying and promoting increased satiety [6]
Therapy techniques, such as cognitive behavioral therapy (CBT), can teach you how to manage emotional causes of binge eating behavior
Intranasal oxytocin pharmacodynamics in the human brain: Dose-response and receptor distribution
The profound success of Obesema 0.5mg relies on its structure as a glucagon-like peptide-1 (GLP-1) receptor agonist, sharing 94% structural homology with native human GLP-1